MS

Mark K. Schlegel

AP Alnylam Pharmaceuticals: 8 patents #4 of 46Top 9%
VB Vir Biotechnology: 1 patents #1 of 9Top 15%
📍 Lexington, MA: #10 of 369 inventorsTop 3%
🗺 Massachusetts: #129 of 11,797 inventorsTop 2%
Overall (2025): #9,185 of 469,880Top 2%
8
Patents 2025

Issued Patents 2025

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12416006 Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof Jeffrey Zuber, James D. McIninch, Adam Castoreno, Lucas D. BonDurant, DHAVAL OZA 2025-09-16
12404508 Ketohexokinase (KHK) iRNA compositions and methods of use thereof Leila Noetzli, James D. McIninch, Frederic Tremblay, Adam Castoreno 2025-09-02
12391945 Coronavirus IRNA compositions and methods of use thereof Akin Akinc, James D. McIninch, Yesseinia Anglero-Rodriguez, Christy M. Hebner, Florian A. Lempp 2025-08-19
12365896 Complement component C3 iRNA compositions and methods of use thereof Mark Keating, James D. McIninch, Elane Fishilevich, Kristina Yucius, Sarah Solomon +2 more 2025-07-22
12331297 Coagulation factor V (F5) iRNA compositions and methods of use thereof Mark Keating, James D. McIninch 2025-06-17
12275938 Modified RNA agents with reduced off-target effect Shigeo Matsuda, Maja Janas, Vasant Jadhav, Martin Maier, Klaus Charisse +3 more 2025-04-15
12258565 Complement component C3 iRNA compositions and methods of use thereof Mark Keating, James D. McIninch, Elane Fishilevich, Kristina Yucius, Sarah Solomon +2 more 2025-03-25
12247203 Modified RNA agents with reduced off-target effect Shigeo Matsuda, Maja Janas, Vasant Jadhav, Martin Maier, Klaus Charisse +3 more 2025-03-11